Literature DB >> 35142858

A novel long-term intravenous combined with local treatment with human amnion-derived mesenchymal stem cells for a multidisciplinary rescued uremic calciphylaxis patient and the underlying mechanism.

Lianju Qin1, Jing Zhang2, Yujie Xiao2, Kang Liu2, Yugui Cui1, Fangyan Xu2, Wenkai Ren2, Yanggang Yuan2, Chunyan Jiang1, Song Ning1, Xiaoxue Ye2, Ming Zeng2, Hanyang Qian2, Anning Bian2, Fan Li2, Guang Yang2, Shaowen Tang3, Zhihong Zhang4, Juncheng Dai3, Jing Guo5, Qiang Wang6, Bin Sun2, Yifei Ge2, Chun Ouyang2, Xueqiang Xu2, Jing Wang2, Yaoyu Huang2, Hongqing Cui2, Jing Zhou1, Meilian Wang7, Zhonglan Su8, Yan Lu8, Di Wu8, Jingping Shi9, Wei Liu10, Li Dong11, Yinbing Pan12, Baiqiao Zhao2,13, Ying Cui2,14, Xueyan Gao2,15, Zhanhui Gao2,16, Xiang Ma1, Aiqin Chen1, Jie Wang1, Meng Cao1, Qian Cui1, Li Chen1, Feng Chen17, Youjia Yu17, Qiang Ji17, Zhiwei Zhang17, Mufeng Gu18, Xiaojun Zhuang18, Xiaolin Lv2, Hui Wang2, Yanyan Pan2, Ling Wang2, Xianrong Xu2, Jing Zhao19, Xiuqin Wang20, Cuiping Liu21, Ningxia Liang22, Changying Xing2, Jiayin Liu1, Ningning Wang2.   

Abstract

Calciphylaxis is a rare disease characterized histologically by microvessel calcification and microthrombosis, with high mortality and no proven therapy. Here, we reported a severe uremic calciphylaxis patient with progressive skin ischemia, large areas of painful malodorous ulcers, and mummified legs. Because of the worsening symptoms and signs refractory to conventional therapies, treatment with human amnion-derived mesenchymal stem cells (hAMSCs) was approved. Preclinical release inspections of hAMSCs, efficacy, and safety assessment, including cytokine secretory ability, immunocompetence, tumorigenicity, and genetics analysis in vitro, were introduced. We further performed acute and long-term hAMSC toxicity evaluations in C57BL/6 mice and rats, abnormal immune response tests in C57BL/6 mice, and tumorigenicity tests in neonatal Balbc-nu nude mice. After the preclinical research, the patient was treated with hAMSCs by intravenous and local intramuscular injection and external supernatant application to the ulcers. When followed up to 15 months, the blood-based markers of bone and mineral metabolism improved, with skin soft tissue regeneration and a more favorable profile of peripheral blood mononuclear cells. Skin biopsy after 1-month treatment showed vascular regeneration with mature noncalcified vessels within the dermis, and 20 months later, the re-epithelialization restored the integrity of the damaged site. No infusion or local treatment-related adverse events occurred. Thus, this novel long-term intravenous combined with local treatment with hAMSCs warrants further investigation as a potential regenerative treatment for uremic calciphylaxis due to effects of inhibiting vascular calcification, stimulating angiogenesis and myogenesis, anti-inflammatory and immune modulation, multidifferentiation, re-epithelialization, and restoration of integrity.
© The Author(s) (2022). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, CEMCS, CAS.

Entities:  

Keywords:  calciphylaxis; chronic kidney disease; human amnion-derived mesenchymal stem cells; multidisciplinary rescue; preclinical research; regenerative medicine; vascular calcification

Mesh:

Year:  2022        PMID: 35142858      PMCID: PMC9205756          DOI: 10.1093/jmcb/mjac010

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   8.185


  51 in total

1.  Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells.

Authors:  Tullia Maraldi; Francesca Beretti; Marianna Guida; Manuela Zavatti; Anto De Pol
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

Review 2.  Muscle as a secretory organ.

Authors:  Bente K Pedersen
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model.

Authors:  Haitao Sun; Zongliu Hou; Huaqiang Yang; Mingyao Meng; Peng Li; Qingjian Zou; Lujun Yang; Yuxin Chen; Huihui Chai; Huilin Zhong; Zara Zhuyun Yang; Jing Zhao; Liangxue Lai; Xiaodan Jiang; Zhicheng Xiao
Journal:  Cell Tissue Res       Date:  2014-06-08       Impact factor: 5.249

4.  HGF Reduces Disease Severity and Inflammation by Attenuating the NF-κB Signaling in a Rat Model of Pulmonary Artery Hypertension.

Authors:  Ying Pang; Ming-Ting Liang; Ying Gong; Yong Yang; Pei-Li Bu; Mei Zhang; Heng-Chen Yao
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 5.  Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.

Authors:  Ting Peng; Ling Zhuo; Ying Wang; Min Jun; Guisen Li; Li Wang; Daqing Hong
Journal:  Nephrology (Carlton)       Date:  2018-07       Impact factor: 2.506

Review 6.  The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration.

Authors:  Carl Randall Harrell; Bojana Simovic Markovic; Crissy Fellabaum; Nebojsa Arsenijevic; Valentin Djonov; Vladislav Volarevic
Journal:  Biofactors       Date:  2019-11-22       Impact factor: 6.113

7.  Exosomal miR-135a derived from human amnion mesenchymal stem cells promotes cutaneous wound healing in rats and fibroblast migration by directly inhibiting LATS2 expression.

Authors:  Shaoying Gao; Tao Chen; Yi Hao; Feifei Zhang; Xiujun Tang; Dali Wang; Zairong Wei; Jianping Qi
Journal:  Stem Cell Res Ther       Date:  2020-02-13       Impact factor: 6.832

8.  Bone mesenchymal stem cell derived exosomes alleviate high phosphorus-induced calcification of vascular smooth muscle cells through the NONHSAT 084969.2/NF-κB axis.

Authors:  Yingjie Liu; Shumin Bao; Weikang Guo; Wenhu Liu
Journal:  Aging (Albany NY)       Date:  2021-06-24       Impact factor: 5.682

9.  Chapter 1: Diagnosis and evaluation of anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08

10.  Mir-29b mediates the regulation of Nrf2 on airway epithelial remodeling and Th1/Th2 differentiation in COPD rats.

Authors:  Yumin Chi; Qingguo Di; Guangchao Han; Min Li; Baohua Sun
Journal:  Saudi J Biol Sci       Date:  2019-07-25       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.